06/04/2025
3:05 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:05 PM | Aura Biosciences (Issuer)
Gibney Anthony S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
3:07 PM | Aura Biosciences (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
| Form SCHEDULE 13G | |
05/20/2025
4:34 PM | Aura Biosciences (Issuer)
Gibney Anthony S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
4:43 PM | Aura Biosciences (Issuer)
Johnson David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2025
6:13 AM | Aura Biosciences (Filer)
| Form 424B5 | |
05/15/2025
5:38 AM | Aura Biosciences (Filer)
| Form 424B5 | |
05/15/2025
5:02 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
5:05 AM | Aura Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2025
2:28 PM | Aura Biosciences (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/13/2025
4:28 PM | Aura Biosciences (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for AURA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aura Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
04/24/2025
3:15 PM | Aura Biosciences (Filer)
| Form DEF 14A | |
04/24/2025
3:17 PM | Aura Biosciences (Filer)
| Form DEFA14A | |
04/24/2025
3:18 PM | Aura Biosciences (Filer)
| Form ARS | |
04/16/2025
7:36 PM | Aura Biosciences (Issuer)
Kilroy Conor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
7:36 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
7:37 PM | Aura Biosciences (Subject)
Kilroy Conor (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2025
7:37 PM | Aura Biosciences (Subject)
Elazzouzi Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2025
4:57 PM | Aura Biosciences (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G | |
04/02/2025
6:15 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
4:15 PM | Aura Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/24/2025
4:00 PM | Aura Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/18/2025
6:30 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:30 PM | Aura Biosciences (Issuer)
Hopkins Janet Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:31 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:31 PM | Aura Biosciences (Issuer)
Plavsic Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:31 PM | Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
6:32 PM | Aura Biosciences (Subject)
Elazzouzi Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
6:32 PM | Aura Biosciences (Subject)
Hopkins Janet Jill (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
6:32 PM | Aura Biosciences (Subject)
Plavsic Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
10:56 AM | Aura Biosciences (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/04/2025
4:51 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:51 PM | Aura Biosciences (Issuer)
Kilroy Conor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:51 PM | Aura Biosciences (Issuer)
Hopkins Janet Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:52 PM | Aura Biosciences (Issuer)
Plavsic Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:52 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
8:09 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
8:09 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
8:10 PM | Aura Biosciences (Subject)
Elazzouzi Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
8:10 PM | Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2025
6:20 PM | Aura Biosciences (Subject)
Long Focus Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
Trump wipes out trillions overnight… (Ad) Is there anybody more powerful than Donald Trump right now?
In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones…
Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move. Whether you take some of that wealth for yourself depends on if you watch this controversial exposé |
11/18/2024
8:06 PM | Aura Biosciences (Issuer)
Hopkins Janet Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
6:32 PM | Aura Biosciences (Subject)
Hopkins Janet Jill (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
4:50 PM | Aura Biosciences (Subject)
Lundbeckfond Invest A/S (Filed by)
| Form SC 13G/A | |
11/12/2024
8:32 AM | Adage Capital Management, L.P. (Filed by)
Aura Biosciences (Subject)
| Form SC 13G/A | |
10/29/2024
7:33 PM | Aura Biosciences (Subject)
Feder Julie B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
7:33 PM | Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
7:38 PM | Aura Biosciences (Subject)
Elazzouzi Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
7:23 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
7:28 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
7:18 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
5:06 PM | Aura Biosciences (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
10/21/2024
5:23 PM | Aura Biosciences (Issuer)
Feder Julie B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
7:08 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:21 PM | Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:21 PM | Aura Biosciences (Subject)
Feder Julie B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
4:10 PM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
8:22 PM | Aura Biosciences (Subject)
Plavsic Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
8:25 PM | Aura Biosciences (Issuer)
Plavsic Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:08 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:05 PM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
5:50 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:05 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:10 AM | Aura Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
